Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer.

International journal of clinical oncology·2026
Same author

Evaluating time to treatment intensification among drug naïve type 2 diabetes patients: a comparison of initial combination therapy vs step-therapy approaches.

Current medical research and opinion·2026
Same author

Effect of the initial combination approach vs initial monotherapy approach on 1-year trajectories of adherence in drug-naive patients with type 2 diabetes.

Journal of managed care & specialty pharmacy·2026
Same author

Interventions to improve adherence to oral endocrine therapy for prevention or treatment of breast cancer in Black women of low socioeconomic status.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

Identification of factors associated with non-adherence to oral endocrine therapy in breast cancer patients of low socioeconomic status: a single centre retrospective study.

International journal of clinical pharmacy·2025
Same author

Prediction of antipsychotic associated weight gain in children and adolescents taking second generation antipsychotics: A machine learning approach.

Journal of psychiatric research·2025
Same journal

<i>Corrigendum to:</i> Identifying and Measuring Caregiver Burdens: A Scoping Review.

Population health management·2026
Same journal

When Administrative Requirements Shape Access: Medicaid Work Requirements and Mental Health Care.

Population health management·2026
Same journal

Screening for and Addressing Social Determinants of Health at Transitions of Care.

Population health management·2026
Same journal

When Sleep Hurts the Joints: Longitudinal Associations of Sleep Quality and Duration with Incident Arthritis in the English Longitudinal Study of Aging.

Population health management·2026
Same journal

It's Time to Build the Infrastructure that Makes Health Possible: Formalizing Accountable Communities for Health.

Population health management·2026
Same journal

Point-of-Care A1C and Time from Test to Communication of Results in Primary Care.

Population health management·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Differences in obesity management among physicians.

Hemalkumar Mehta1, Jeetvan Patel, Rohan Parikh

  • 1Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, Houston, TX 77030, USA.

Population Health Management
|July 14, 2012
PubMed
Summary
This summary is machine-generated.

Primary care physicians provide more obesity management than other doctors, yet overall treatment remains low. Further research is needed to understand and address disparities in obesity care for all patients.

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Related Experiment Videos

Last Updated: May 20, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Area of Science:

  • Public Health
  • Clinical Medicine
  • Health Services Research

Background:

  • Intensive obesity management is recommended but not universally provided to obese patients.
  • Disparities exist in the delivery of obesity care within healthcare systems.

Purpose of the Study:

  • To investigate differences in obesity management between primary care physicians (PCPs) and non-PCPs.
  • To identify factors influencing the provision of obesity management during ambulatory care visits.

Main Methods:

  • Cross-sectional study utilizing the 2006-2007 National Ambulatory Medical Care Survey.
  • Analysis of adult patients (≥20 years) with obesity (BMI ≥30 kg/m²).
  • Multivariate logistic regression applied, controlling for patient characteristics based on Anderson's behavioral model.

Main Results:

  • Obesity management was documented in 32.66% of visits by obese patients.
  • PCPs were 2.38 times more likely to provide obesity management compared to non-PCPs.
  • Preventive and chronic care visits increased the likelihood of receiving obesity management.

Conclusions:

  • Significant differences in obesity management exist between PCPs and non-PCPs.
  • Only one-third of ambulatory visits for obese patients resulted in documented obesity management.
  • Further research is crucial to understand disparities and improve equitable access to obesity care.